Mexico: Higher Drug VAT Plan Slammed

6 October 1996

Uprofram, the Mexican union of pharmacy owners, has attacked plans by the Ministry of Commerce to raise value-added tax, now at 15% for most products, on pharmaceuticals.

Uprofram president Julian Vazquez Morales said that with prices now rising virtually indiscriminately, with no controls by the Department of Commerce, drugs are "already inaccessible" for most Mexicans. He added, the extra tax would contravene Article 4 of the Constitution and the general health law.

He said the rising prices were due to the "monopolistic nature" of drug distributors, some of which had now set up their own pharmacies offering discounts, but that these were false savings, since the original prices had been inflated.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight